NASDAQ:SIGA
SIGA Stock News
$10.39
+0.240 (+2.36%)
At Close: May 06, 2024
SIGA Technologies to Host Business Update Call on August 5th, 2021 Following Release of Second Quarter 2021 Financial Results
04:15pm, Thursday, 29'th Jul 2021
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has
SIGA Supplies TPOXX® (Tecovirimat) as Compassionate Treatment for Monkeypox Case in the United Kingdom
07:30am, Wednesday, 30'th Jun 2021
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it prov
4 Undervalued Biotech Stocks That Belong On Every Investor's Buy List
04:36pm, Thursday, 17'th Jun 2021
Searching for undervalued biotech stocks? Here are 4 biotech stocks to buy for a mix of value and growth in any portfolio.
7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts
03:45pm, Wednesday, 12'th May 2021
Small-cap stocks in the biotech space have been in a slump, but these seven companies could see big moves just around the corner. The post 7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts ap
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q1 2021 Results - Earnings Call Transcript
01:57am, Sunday, 09'th May 2021
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q1 2021 Results - Earnings Call Transcript
SIGA Announces New Drug Application Filing with FDA for Intravenous Formulation of TPOXX
07:30am, Tuesday, 04'th May 2021
- Important for Patients Who Cannot Swallow Oral Capsules - - Important for Patients Who Cannot Swallow Oral Capsules -
SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX
10:06pm, Tuesday, 27'th Apr 2021
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company developing drugs for health security and infectious diseases globally with a market niche in smallpox servicing various government
MUMBAI, India, March 23, 2021 /PRNewswire/ -- Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (herein referred to as "Cipla") and SIGA Technologies, Inc. (SIGA) (NASDA
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q4 2020 Results - Earnings Call Transcript
06:39pm, Thursday, 04'th Mar 2021
SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q4 2020 Results - Earnings Call Transcript
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2020
04:05pm, Thursday, 04'th Mar 2021
- Approximately 363,000 Courses of Oral TPOXX® Delivered to U.S. Government in 2020 –
SIGA Technologies to Host Business Update Call on March 4, 2021 Following Release of Year End 2020 Financial Results
07:30am, Friday, 26'th Feb 2021
NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that managem
3 Magic Formula Stocks for the Value Investor
03:26pm, Sunday, 21'st Feb 2021
If you want to increase your chances of beating the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.
SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®
04:45pm, Wednesday, 13'th Jan 2021
Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXX
SIGA Technologies Chief Scientific Officer to Participate at NCT Asia Virtual Conference on November 13, 2020
04:05pm, Thursday, 12'th Nov 2020
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Den
